|
2025
|
Invention
|
Azasetron for the prevention of hearing loss in subjects receiving cisplatin. The present inventi... |
|
2024
|
Invention
|
Intra cochlear administration device. 1101020311120213031113010303). |
|
|
Invention
|
Intra cochlear administration device |
|
|
Invention
|
Azasetron for the preservation of residual hearing following cochlear implantation. The present i... |
|
|
Invention
|
Azasetron for the preservation of residual hearing following cochlear implantation |
|
|
Invention
|
Adeno-associated virus vector encoding connexin 26 and uses thereof. The present invention relate... |
|
|
Invention
|
Adeno-associated virus vector encoding connexin 26 and uses thereof |
|
2023
|
Invention
|
Mini syringe driver.
A syringe driver configured to automatically empty a mini-syringe extending... |
|
|
Invention
|
Regulatory sequences comprising microrna target sites.
An isolated nucleic acid sequence includi... |
|
|
Invention
|
Regulatory sequences comprising microrna target sites. The present invention relates to an isolat... |
|
|
Invention
|
Regulatory sequences comprising microrna target sites |
|
|
Invention
|
Azasetron for the treatment of sudden sensorineural hearing loss.
Azasetron or an analog thereof... |
|
|
Invention
|
Azasetron for the treatment of sudden sensorineural hearing loss. The present invention relates t... |
|
|
Invention
|
Method of preventing cochlear disease, disorder or condition using (+)-azasetron.
Disclosed is a... |
|
2022
|
Invention
|
Calcineurin inhibitors of the setron family for the treatment of hearing loss.
Disclosed is an i... |
|
2020
|
Invention
|
Treatment and/or prevention of lesions in the central auditory nervous system.
The therapeutic u... |
|
|
Invention
|
Treatment and/or prevention of lesions in the central auditory nervous system. The present invent... |
|
2018
|
Invention
|
Synthesis of 4-aminopyrimidine compounds. terttert-butyl azetidin- 3-yl(methyl)carbamate, or anot... |
|
2017
|
Invention
|
(+)-azasetron for use in the treatment of ear disorders. Disclosed is a method for treating ear d... |
|
|
Invention
|
(+)-azasetron for use in the treatment of ear disorders. The present invention relates to (+)-aza... |
|
2016
|
Invention
|
Calcineurin inhibitors of the setron family for the treatment of hearing loss. Disclosed is an in... |
|
|
Invention
|
Calcineurin inhibitors of the setron family for the treatment of hearing loss. The present invent... |
|
2015
|
Invention
|
Compounds for preventing ototoxicity. The present invention relates to a compound for use for pre... |
|
|
P/S
|
Chemicals for use in science used in the manufacture of pharmaceuticals and prevention's medicine... |
|
|
P/S
|
Chemical preparations for use in science; chemical preparations in the nature of bases for use in... |
|
|
P/S
|
Chemical products for use in science, bases (chemical
products), chemical products used for the ... |
|
2014
|
Invention
|
Methods for treating vestibulotoxicty.
The present invention relates to a method for treating pl... |
|
2013
|
Invention
|
H4 receptor inhibitors for treating tinnitus. The invention relates to Histamine type 4 receptor ... |
|
|
Invention
|
Methods for treating vestibulotoxicity. The present invention relates to a compound that impairs ... |
|
|
Invention
|
Calcineurin inhibitors for use in the treatment of lesional vestibular disorders. The present inv... |
|
2012
|
P/S
|
Chemicals for use in science, Bases (chemical preparations), Chemical products for use in the man... |
